Pharmaceuticals, Biotechnology and Life Sciences
Lille (France), Cambridge (Massachusetts, United States), September 13, 2022 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated…
INDIANAPOLIS, Sept. 13, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating…
Company announcement – No. 40 / 2022 Zealand Pharma grants warrants to employees in Denmark Copenhagen, DK and Boston, MA,…
– Company expects to report top-line data from China pivotal trial for lead drug candidate CBP-201 in atopic dermatitis in…
Initial Phase 1/2a clinical findings for LAVA-051 in patients with chronic lymphocytic leukemia and multiple myeloma patients demonstrated encouraging anti-tumor…
SOUTH SAN FRANCISCO, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
HOUSTON, Sept. 13, 2022 (GLOBE NEWSWIRE) — Texas Biotechnology Inc., a Houston based company, is pleased to announce that it…
BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing…
Orion Corporation NOTIFICATION 13.09.2022 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 13.09.2022 Date 13.09.2022 Exchange transaction Buy …